Concepedia

Suresh Babu

SB

Statistics

Publications

5

Citations

261

H-Index

5

Active since

1989

Affiliations

Ligand Pharmaceuticals (United States)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Suresh Babu is an author at Ligand Pharmaceuticals (United States) specializing in drug discovery, medicinal chemistry, and potency optimization.

Publications per year

1989–2012

5

Publications

5

Discovery of an Orally Available, Brain Penetrant BACE1 Inhibitor That Affords Robust CNS Aβ Reduction

Andrew W. Stamford, Jack D. Scott, Sarah W. Li et al. · ACS Medicinal Chemistry Letters · 2012 · 99 citations · Full text

, , +14

Preparation of 3-acetyl-2-hydroxyindoles via rhodium carbenoid aromatic carbon-hydrogen insertion

Nola Etkin, Suresh Babu, Catherine J. Fooks et al. · The Journal of Organic Chemistry · 1990 · 64 citations

, , +6

Piperazine sulfonamide BACE1 inhibitors: Design, synthesis, and in vivo characterization

Jared N. Cumming, Suresh Babu, Ying Huang et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 47 citations · Full text

, , +10

Intramolecular rhodium carbenoid insertions into aromatic C—H bonds. Preparation of 1,3-dihydrothiophene 2,2-dioxides fused onto aromatic rings

Suresh Babu, Michael D. Hrytsak, Tony Durst · Canadian Journal of Chemistry · 1989 · 35 citations

, , +15

Discovery and SAR of biaryl piperidine MCH1 receptor antagonists through solid-phase encoded combinatorial synthesis

Tao Guo, Yuefei Shao, Gang Qian et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 16 citations · Full text

, , +14

1–5 of 5